Biotechnology is the new capital. The many stakeholders
in this revolution include scientists, technologists,
managers, and venture capitalists; health care,
agricultural, chemical, and pharmaceutical industries;
law professionals and ethicists; public policymakers;
and, finally, the society and individuals who are in the
midst of all that is taking place. Kellogg on
Biotechnology is the outgrowth of TechVentures, a
collaborative student-faculty effort at the Kellogg
School of Management. The contributors walk the reader
through the "what" - what are some of the newest
biotechnologies that will revolutionize the way we think
about health? the "how" - how to transform those
technologies into profitable products and companies; and
the "who" - who will benefit from these technologies.